Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Correspondence
Nature Medicine 13, 1278 (1 November 2007) | doi:10.1038/nm1107-1278;
Reply to 'Arsenic patent keeps drug for rare cancer out of reach for many'
Abstract
To the editor: In his news article “Arsenic patent keeps drug for rare cancer out of reach of many”, your reporter got his facts right, but I suggest that his editor muffed the title. Here's an accurate headline: “Patent got drug into the hands of many quickly.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
